ClinicalTrials.Veeva

Menu
O

Ospedale Pediatrico Bambino Gesu | Dipartimento di Oncoematologia e Terapia Cellulare e Genica

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ataluren
VX-445
ELX
Tezacaftor
Ivacaftor
Elexacaftor
Emapalumab
TEZ
Ceftazidime
Anti-interferon

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 26 total trials

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis (Galapeduca)

The aim of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of filgotinib as a treatment for UC in children an...

Not yet enrolling
Ulcerative Colitis
Drug: Filgotinib
Status recently updated

This is a study of the investigational medicine ENTR-601-44 in participants who have Duchenne muscular dystrophy (DMD), a rare genetic condition.The...

Not yet enrolling
Enrolling
Duchenne Muscular Dystrophy (DMD)
Drug: ENTR-601-44 - matching placebo
Drug: ENTR-601-44

This is a study of the investigational medicine ENTR-601-45 in participants who have Duchenne muscular dystrophy (DMD), a rare genetic condition. The...

Begins enrollment in 2 months
Duchenne Muscular Dystrophy (DMD)
Drug: ENTR-601-45
Drug: ENTR-601-45 - matching placebo

The AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular d...

Active, not recruiting
Immunoglobulin A Nephropathy
Alport Syndrome
Drug: Atrasentan

This is a Phase 1-2, multicenter, international, single-arm, open-label study designed to identify a recommended dose of bosutinib administered orall...

Active, not recruiting
Blastic Phase Chronic Myelogenous Leukemia
Chronic Phase Chronic Myelogenous Leukemia
Drug: Bosutinib

The main purpose of this study is to demonstrate that the growth of infants fed with the Test Formula is non-inferior those fed with the Control Form...

Not yet enrolling
Cow Milk Protein Allergy
Other: Control Formula
Other: Test Formula

The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric and adult participan...

Enrolling
Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
Drug: Maralixibat
Other: Placebo

The intent and design of this Phase 3 study is to assess vosoritide as a therapeutic option for the treatment of children with hypochondroplasia (HCH...

Invitation-only
Hypochondroplasia
Drug: Vosoritide
Drug: Placebo

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modifi...

Enrolling
Neoplasms
Genetic: Gene-modified (GM) T cell therapy

The purpose of this study is to assess the long-term safety and effectiveness of odevixibat in participants with Alagille syndrome (ALGS).The partici...

Enrolling
Alagille Syndrome
Drug: Odevixibat

This study will evaluate the long-term safety, efficacy and pharmacodynamics of ELX/TEZ/IVA in participants with cystic fibrosis (CF) with at least 1...

Active, not recruiting
Cystic Fibrosis
Drug: ELX/TEZ/IVA
Drug: IVA

Trial sponsors

Vertex Pharmaceuticals logo
PTC Therapeutics logo
E
Sobi logo
Agios Pharmaceuticals logo
A
A
BioMarin Pharmaceutical logo
Celgene logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems